PI
TERN

PEAK6 Investments’s Terns Pharmaceuticals TERN Stock Holding History

PEAK6 Investments’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,097
Closed -$96.1K – 4832
2023
Q3 		$96.1K Buy
19,097
+5,000
+35% +$31.7K ﹤0.01% 3413
2023
Q2 		$123K Buy
+14,097
New +$164K ﹤0.01% 3142
2022
Q3 		– Sell
-14,097
Closed -$123K – 6092
2022
Q2 		$123K Buy
+14,097
New +$28.2K ﹤0.01% 5118

Other funds holding TERN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PEAK6 Investments's TERN Position: Q4 2023 in Review

PEAK6 Investments sold out of Terns Pharmaceuticals (TERN) in Q4 2023, closing a stake of 19,097 shares — an estimated $96.1K sold.

PEAK6 Investments first reported a position in TERN in Q2 2022 and held it in 3 quarters. The position peaked at $123K in Q2 2023. 103 funds tracked by Wall St. Rank hold TERN as of Q4 2023.

  • PEAK6 Investments reported no remaining Terns Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 19,097 Terns Pharmaceuticals shares in Q4 2023, an estimated $96.1K.
  • PEAK6 Investments first reported a position in Terns Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • PEAK6 Investments's Terns Pharmaceuticals position peaked at $123K in Q2 2023.
  • 103 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.